THERAPEUTIC AREA COMPOUND INDICATION PRE-CLINICAL CLINICAL
    ONCOLOGY CLX-ONC-5516 Colorectal Cancer
  • CLX-ONC-55A3 Gastric Cancer
  • CLX-ONC-55A9 Advanced Breast Cancer
  • CLX-ONC-164A2 Brain Cancer
  • CLX-ONC-575 Familial Adenomatous Polyposis (FAP)
  • CLX-ONC-643 Anaplastic Astrocytoma
  • CLX-ONC-55A6 Advanced Ovarian Cancer
  • CLX-ONC-5516 Breast Cancer
  • CLX-ONC-55A6 Pancreatic Cancer
  • OPHTHALMOLOGY CLX-OPH-56 Glaucoma
  • CLX-OPH-561 Presbyopia
  • CLX-OPH-62D Myopia
  • CLX-OPH-62 Glaucoma
  • CLX-OPH-621 Dry Eye
  • CLX-OPH-622 Ocular Redness
  • CLX-OPH-65 Cataract
  • NEUROLOGY CLX-NEU-06 Multiple Sclerosis
  • CLX-NEU-61 Major Depressive Disorder
  • CLX-NEU-161A11 Postsurgical Local Analgesia
  • GASTROINTESTINAL CLX-GI-03 Ulcerative Colitis
  • CLX-GI-3A5 Paediatric Ulcerative Colitis
  • CLX-GI-62D2 Fecal Incontinence
  • INFECTIOUS DISEASES CLX-IFN-59 Systemic Fungal Infections
  • PULMONOLOGY CLX-PUL-597E Allergic Bronchopulmonary Aspergillosis
  • CLX-PUL-5910E Invasive Pulmonary Aspergillosis
  • METABOLIC DISEASES CLX-MET-101 Diabetes and Lipid Disorders
  • CLX-MET-102 Type 2 Diabetes Metformin
  • DERMATOLOGY CLX-DER-622 Rosacea
  • CLX-DER-64C2 Acne
  • CLX-DER-62C2 Rosacea
  • CLX-DER-64C3 Rosacea